XORTX Therapeutics (XRTX) Payables (2020 - 2026)
XORTX Therapeutics (XRTX) posted Payables of $845932.0 for Q1 2026, up 50.58% on a QoQ basis from $561784.0 in Q4 2025, and up 14.05% year-over-year from $741688.0 in Q1 2025.
XORTX Therapeutics (XRTX) Payables (2020 - 2026) Analysis & Trends
XORTX Therapeutics' Payables history runs 7 years deep, the most recent figure standing at $845932.0 for Q1 2026.
- Quarterly Payables rose 14.05% year-over-year to $845932.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $845932.0 (up 14.05% YoY) and the FY2025 annual result came in at $561784.0, down 21.89% from the prior year.
- Payables was $845932.0 for Q1 2026 at XORTX Therapeutics, up from $561784.0 in the prior quarter.
- Across five years, Payables topped out at $5.3 million in Q4 2022 and bottomed at $358077.0 in Q2 2023.
- A 5-year average of $1.8 million and a median of $812123.0 in 2025 frame the typical range for Payables.
- Annual changes were most pronounced in 2023 — Payables sank 87.51% — and 2024, when it jumped 558.69%.
- XORTX Therapeutics' Payables stood at $5.3 million in 2022, then plunged by 90.07% to $525245.0 in 2023, then surged by 36.93% to $719205.0 in 2024, then fell by 21.89% to $561784.0 in 2025, then soared by 50.58% to $845932.0 in 2026.
- Business Quant data shows XRTX's Payables at $845932.0 in Q1 2026, $561784.0 in Q4 2025, and $778314.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 5.74 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 10.62 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 423.55 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 694,346.76 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 489.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.03 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.52 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 80.54 Mn |
| 10 | XORTX Therapeutics | 20.40 Mn | 20.40 Mn | - | 845,932.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 845,932.00 |
| Dec 31, 2025 | 561,784.00 |
| Sep 30, 2025 | 778,314.00 |
| Jun 30, 2025 | 630,982.00 |
| Mar 31, 2025 | 741,688.00 |
| Dec 31, 2024 | 719,205.00 |
| Sep 30, 2024 | 1.66 Mn |
| Jun 30, 2024 | 2.01 Mn |
| Mar 31, 2024 | 3.55 Mn |
| Sep 30, 2023 | 525,245.00 |
| Jun 30, 2023 | 358,077.00 |
| Mar 31, 2023 | 538,252.00 |
| Dec 31, 2022 | 5.29 Mn |
| Sep 30, 2022 | 3.16 Mn |
| Jun 30, 2022 | 2.87 Mn |
| Mar 31, 2022 | 3.98 Mn |
| Dec 31, 2021 | 4.20 Mn |
| Sep 30, 2021 | 9.59 Mn |
| Dec 31, 2020 | 793,297.91 |